A PYMNTS Company

Australia: Antitrust authority approves new regulations to increase pharma transparency

By  |  January 8, 2013

The Australian Competition and Consumer Commission has given Australia’s pharmaceutical companies a timeline of two years to improve transparency in regards to the companies’ payments and sponsorships to healthcare professionals. While originally sought for a five year acceptance, Medicines Australia’s most recent Code of Conduct has been approved for two years; the new regulations are aimed at ensuring the makers of prescription drugs disclose the doctors and consumer groups they pay.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: PharmaTimes

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.